Concepedia

Q.S-C. Chu

QC

Statistics

Publications

3

Citations

115

H-Index

3

Active since

2011

Affiliations

University of Alberta(Current)

Q.S-C. Chu is an author at University of Alberta specializing in lung cancer, radiation oncology, and cancer therapeutics.

Top concepts

Publications per year

2011–2023

3

Publications

3

An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC)

Mark M. Awad, Q.S-C. Chu, Leena Gandhi et al. · Lung Cancer · 2016 · 62 citations

, , +9

Erlotinib ‘dosing-to-rash’: a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer

Alain C. Mita, K. Papadopoulos, Maja J.A. de Jonge et al. · British Journal of Cancer · 2011 · 42 citations · Full text

VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC

Maximilian J. Hochmair, Karim Vermaelen, G. Mountzios et al. · Annals of Oncology · 2023 · 11 citations

1–3 of 3